MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.
Sustainability
The Menarini Group has embarked on a structured path of sustainability, aware that encouraging the integration of ESG (Environmental, Social and Governance) criteria within its business model is an essential requirement for creating long-lasting value. The strategic directions have been outlined through a comparative analysis of the company activities and the 17 Sustainable Development Goals (SDGs) set for 2030 by the United Nations.
With its sustainability program, the Menarini Group contributes to 12 Sustainable Development Goals.
The Strategic Sustainability Plan aims, on the one hand, to systematize and enhance the initiatives already in place – from an environmental, social and governance perspective – and, on the other hand, to identify significant new opportunities for achieving the SDGs.
The effectiveness of actions is monitored through the use of specific KPIs in the short and medium-long term, which will allow transparent reporting of results to stakeholders.
Global Health in 2025: Forests, Water and AMR Prevention
April 22nd is World Earth Day, a global call to honor and protect the planet we all share. Established in 1970, this annual observance now mobilizes over a billion people in more than 190 countries to take action for the environment. World Earth Day 2025 is a timely reminder that safeguarding nature is not just an ecological responsibility, but a health imperative.
Menarini Group’s health, safety and environmental policy
The Menarini Group has formally established its commitments to reducing environmental impacts and to maintaining the health and safety of all workers who work at their sites in an Health, Safety and Environmental Policy.
